Profiel
Chris Bunge is currently a Senior Analyst at Opaleye Management, Inc. since 2023.
Formerly, Mr. Bunge was a Portfolio Manager at WaterMill Asset Management from 2017 to 2024 and an Analyst at Manalapan Oracle Advisers LLC from 2013 to 2014.
Mr. Bunge completed an undergraduate degree at Bentley University in 2013.
Actieve functies van Chris Bunge
| Bedrijven | Functie | Begin |
|---|---|---|
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Analyst-Equity | 01-11-2023 |
Eerdere bekende functies van Chris Bunge
| Bedrijven | Functie | Einde |
|---|---|---|
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Portefeuillebeheerder-Aandelen | 01-01-2024 |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Analyst-Equity | 01-04-2014 |
Opleiding van Chris Bunge
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Finance |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Finance |
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Finance |
















